These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26575148)

  • 1. Residual inflammation and viral reservoirs: alliance against an HIV cure.
    Massanella M; Fromentin R; Chomont N
    Curr Opin HIV AIDS; 2016 Mar; 11(2):234-41. PubMed ID: 26575148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
    Vandergeeten C; Fromentin R; Chomont N
    Cytokine Growth Factor Rev; 2012; 23(4-5):143-9. PubMed ID: 22743037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Select host restriction factors are associated with HIV persistence during antiretroviral therapy.
    Abdel-Mohsen M; Wang C; Strain MC; Lada SM; Deng X; Cockerham LR; Pilcher CD; Hecht FM; Liegler T; Richman DD; Deeks SG; Pillai SK
    AIDS; 2015 Feb; 29(4):411-20. PubMed ID: 25602681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs.
    Darcis G; Berkhout B; Pasternak AO
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32349381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of immune-modulating compounds to disrupt HIV latency.
    Remoli AL; Marsili G; Battistini A; Sgarbanti M
    Cytokine Growth Factor Rev; 2012; 23(4-5):159-72. PubMed ID: 22766356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
    Rong L; Perelson AS
    PLoS Comput Biol; 2009 Oct; 5(10):e1000533. PubMed ID: 19834532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering natural control of HIV-1: A valuable strategy to achieve antiretroviral therapy termination.
    Loucif H; Gouard S; Dagenais-Lussier X; Murira A; Stäger S; Tremblay C; Van Grevenynghe J
    Cytokine Growth Factor Rev; 2018 Apr; 40():90-98. PubMed ID: 29778137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 promotes HIV persistence during antiretroviral therapy.
    Vandergeeten C; Fromentin R; DaFonseca S; Lawani MB; Sereti I; Lederman MM; Ramgopal M; Routy JP; Sékaly RP; Chomont N
    Blood; 2013 May; 121(21):4321-9. PubMed ID: 23589672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.
    Chomont N; El-Far M; Ancuta P; Trautmann L; Procopio FA; Yassine-Diab B; Boucher G; Boulassel MR; Ghattas G; Brenchley JM; Schacker TW; Hill BJ; Douek DC; Routy JP; Haddad EK; Sékaly RP
    Nat Med; 2009 Aug; 15(8):893-900. PubMed ID: 19543283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
    Suryawanshi P; Bagul R; Shete A; Thakar M
    Front Immunol; 2021; 12():663919. PubMed ID: 33995393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.
    Christensen-Quick A; Vanpouille C; Lisco A; Gianella S
    AIDS Res Hum Retroviruses; 2017 Nov; 33(S1):S23-S30. PubMed ID: 29140108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence.
    Murray AJ; Kwon KJ; Farber DL; Siliciano RF
    J Immunol; 2016 Jul; 197(2):407-17. PubMed ID: 27382129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broad drug arsenal to attack a strenuous latent HIV reservoir.
    Stoszko M; Ne E; Abner E; Mahmoudi T
    Curr Opin Virol; 2019 Oct; 38():37-53. PubMed ID: 31323521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation.
    Reeves DB; Duke ER; Wagner TA; Palmer SE; Spivak AM; Schiffer JT
    Nat Commun; 2018 Nov; 9(1):4811. PubMed ID: 30446650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
    Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
    Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.